Private banks are shifting their allocations to Chinese stocks away from New York-traded ADRs towards those listed in Hong Kong and onshore, citing attractive valuations, supportive policy and less regulatory risk. The change comes as Chinese companies listed in the US face regulatory pressure, both from a looming drive to de-list these groups from American exchanges and a crackdown by…
To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
Subscriber Only Content
This article is available on a corporate subscription with Asian Private Banker. Please login or subscribe to view this content.
Need help? Please see our FAQ Guide or email [email protected]
Have a confidential tip? Get in touch [email protected]
